Balyasny Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
|
|||||
|
2025
Q1 | $181K | Buy |
|
|||||
|
2024
Q4 | $39.6K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $103K | Sell |
|
|||||
|
2024
Q1 | $265K | Buy |
|
|||||
|
2023
Q4 | $84.8K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $7.33M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.55M | Buy |
|
|||||
|
2022
Q3 | $503K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $608K | Buy |
|